Injury-induced insulin resistance in adipose tissue

Biochemical and Biophysical Research Communications

Volumn 421, Issue 3, 2012, Pages 442-448

  Williams, Vanessa L ^a   Martin, Rachel E ^b   Franklin, John L ^b   Hardy, Robert W ^b   Messina, Joseph L ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Adipose tissue; Critical illness diabetes; Hemorrhage; Injury; Insulin resistance; Insulin signaling

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN KINASE B;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RESISTANCE; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SERINE;

RODENTIA;

EID: 84860700149     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.146     Document Type: Article

References (62)

1. Berge R.K., Tronstad K.J., Berge K., Rost T.H., Wergedahl H., Gudbrandsen O.A., Skorve J. The metabolic syndrome and the hepatic fatty acid drainage hypothesis. Biochimie 2005, 87:15-20.
2. Avramoglu R.K., Basciano H., Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin. Chim. Acta 2006, 368:1-19.
3. Mlinar B., Marc J., Janez A., Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin. Chim. Acta 2007, 375:20-35.
4. Ueki K., Kondo T., Tseng Y.H., Kahn C.R. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. USA 2004, 101:10422-10427.
5. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol. Metab. 2003, 14:137-145.
6. Li L., Messina J.L. Acute insulin resistance following injury. Trends Endocrinol. Metab. 2009, 20:429-435.
7. Gore D.C., Chinkes D., Heggers J., Herndon D.N., Wolf S.E., Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J. Trauma 2001, 51:540-544.
8. McCowen K.C., Malhotra A., Bistrian B.R. Stress-induced hyperglycemia. Crit. Care Clin. 2001, 17:107-124.
9. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 2001, 345:1359-1367.
10. Thompson L.H., Kim H.T., Ma Y., Kokorina N., Messina J.L. Acute muscle-type specific insulin resistance following injury. Mol. Med. 2008, 11-12:715-723.
11. Ma Y., Toth B., Keeton A.B., Holland L.T., Chaudry I.H., Messina J.L. Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha. Endocrinology 2004, 145:5168-5176.
12. Ma Y., Wang P., Kuebler J.F., Chaudry I.H., Messina J.L. Hemorrhage induces the rapid development of hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G107-G115.
13. Strommer L., Isaksson B., Wickbom M., Arnelo U., Ostenson C., Herrington M., Permert J. Effect of carbohydrate feeding on insulin action in skeletal muscle after surgical trauma in the rat. Nutrition 2001, 17:332-336.
14. Bochicchio G.V., Sung J., Joshi M., Bochicchio K., Johnson S.B., Meyer W., Scalea T.M. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J. Trauma 2005, 58:921-924.
15. Laird A.M., Miller P.R., Kilgo P.D., Meredith J.W., Chang M.C. Relationship of early hyperglycemia to mortality in trauma patients. J. Trauma 2004, 56:1058-1062.
16. Sung J., Bochicchio G.V., Joshi M., Bochicchio K., Tracy K., Scalea T.M. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J. Trauma 2005, 59:80-83.
17. Yendamuri S., Fulda G.J., Tinkoff G.H. Admission hyperglycemia as a prognostic indicator in trauma. J. Trauma 2003, 55:33-38.
18. Lewis K.S., Kane-Gill S.L., Bobek M.B., Dasta J.F. Intensive insulin therapy for critically ill patients. Ann. Pharmacother. 2004, 38:1243-1251.
19. Pittas A.G., Siegel R.D., Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2004, 164:2005-2011.
20. White M.F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 1998, 182:3-11.
21. Flores-Riveros J.R., Sibley E., Kastelic T., Lane M.D. Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J. Biol. Chem. 1989, 264:21557-21572.
22. Shepherd P.R., Nave B.T., Rincon J., Haigh R.J., Foulstone E., Proud C., Zierath J.R., Siddle K., Wallberg-Henriksson H. Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia 1997, 40:1172-1177.
23. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 1997, 7:261-269.
24. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 1994, 269:3568-3573.
25. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
26. Strommer L., Permert J., Arnelo U., Koehler C., Isaksson B., Larsson J., Lundkvist I., Bjornholm M., Kawano Y., Wallberg H., Zierath J.R. Skeletal muscle insulin resistance after trauma: insulin signaling and glucose transport. Am. J. Physiol. 1998, 275:E351-E358.
27. Li L., Thompson L.H., Zhao L., Messina J.L. Tissue specific difference in the molecular mechanisms for the development of acute insulin resistance following injury. Endocrinology 2009, 150:24-32.
28. Ikezu T., Okamoto T., Yonezawa K., Tompkins R.G., Martyn J.A. Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J. Biol. Chem. 1997, 272:25289-25295.
29. Carter E.A., Burks D., Fischman A.J., White M., Tompkins R.G. Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int. J. Mol. Med. 2004, 14:653-658.
30. Xu J., Kim H.T., Ma Y., Zhao L., Zhai L., Kokorina N., Wang P., Messina J.L. Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor (TNF)-alpha. Endocrinology 2008, 149:2369-2382.
31. Esposito D.L., Li Y., Cama A., Quon M.J. Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 2001, 142:2833-2840.
32. Altavilla D., Saitta A., Guarini S., Galeano M., Squadrito G., Cucinotta D., Santamaria L.B., Mazzeo A.T., Campo G.M., Ferlito M., Minutoli L., Bazzani C., Bertolini A., Caputi A.P., Squadrito F. Oxidative stress causes nuclear factor-kappaB activation in acute hypovolemic hemorrhagic shock. Free Radical Biol. Med. 2001, 30:1055-1066.
33. Xin-Long C., Zhao-Fan X., Dao-Feng B., Jian-Guang T., Duo W. Insulin resistance following thermal injury: an animal study. Burns 2007, 33:480-483.
34. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 1995, 75:473-486.
35. Golay A., Ybarra J. Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:649-663.
36. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
37. Juhan-Vague I., Alessi M.C., Mavri A., Morange P.E. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J. Thromb. Haemost. 2003, 1:1575-1579.
38. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E745-E751.
39. Bosello O., Zamboni M. Visceral obesity and metabolic syndrome. Obes. Rev. 2000, 1:47-56.
40. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115:911-919.
41. Ailhaud G. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C. R. Biol. 2006, 329:570-577.
42. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000, 11:327-332.
43. Garg A. Adipose tissue dysfunction in obesity and lipodystrophy. Clin. Cornerstone 2006, 8(Suppl. 4):S7-S13.
44. Rattarasarn C. Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes. Acta Physiol. (Oxf.) 2006, 186:87-101.
45. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 2004, 89:2595-2600.
46. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 1993, 268:26055-26058.
47. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in tumor necrosis factor-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
48. Sell H., etze-Schroeder D., Kaiser U., Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006, 147:2458-2467.
49. Rotter V., Nagaev I., Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and TNFalpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 2003, 278:45777-45784.
50. Senn J.J., Klover P.J., Nowak I.A., Zimmers T.A., Koniaris L.G., Furlanetto R.W., Mooney R.A. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 2003, 278:13740-13746.
51. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
52. Harman-Boehm I., Bluher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., Shai I., Kloting N., Stumvoll M., Bashan N., Rudich A. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J. Clin. Endocrinol. Metab. 2007, 92:2240-2247.
53. Permana P.A., Menge C., Reaven P.D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem. Biophys. Res. Commun. 2006, 341:507-514.
54. Egi M., Bellomo R., Stachowski E., French C.J., Hart G.K., Hegarty C., Bailey M. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit. Care Med. 2008, 36:2249-2255.
55. Ellger B., Debaveye Y., Vanhorebeek I., Langouche L., Giulietti A., Van E.E., Herijgers P., Mathieu C., Van den Berghe G. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006, 55:1096-1105.
56. Hafidh S.A., Reuter M.D., Chassels L.J., Aradhyula S., Bhutto S.S., Alpert M.A. Effect of intravenous insulin therapy on clinical outcomes in critically ill patients. Am. J. Med. Sci. 2007, 333:354-361.
57. Scalea T.M., Bochicchio G.V., Bochicchio K.M., Johnson S.B., Joshi M., Pyle A. Tight glycemic control in critically injured trauma patients. Ann. Surg. 2007, 246:605-610.
58. Sleiman I., Morandi A., Sabatini T., Ranhoff A., Ricci A., Rozzini R., Trabucchi M. Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit. J. Am. Geriatr. Soc. 2008, 56:1106-1110.
59. Tamaki M., Shimizu T., Kanazawa A., Tamura Y., Hanzawa A., Ebato C., Itou C., Yasunari E., Sanke H., Abe H., Kawai J., Okayama K., Matsumoto K., Komiya K., Kawaguchi M., Inagaki N., Watanabe T., Kanazawa Y., Hirose T., Kawamori R., Watada H. Efficacy and safety of modified Yale insulin infusion protocol in Japanese diabetic patients after open-heart surgery. Diabetes Res. Clin. Pract. 2008, 81:296-302.
60. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V., Bellomo R., Cook D., Dodek P., Henderson W.R., Hebert P.C., Heritier S., Heyland D.K., McArthur C., McDonald E., Mitchell I., Myburgh J.A., Norton R., Potter J., Robinson B.G., Ronco J.J. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009, 360:1283-1297.
61. Merz T.M., Finfer S. Pro/con debate: is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients?. Crit. Care 2008, 12:212.
62. Vriesendorp T.M., DeVries J.H., Hoekstra J.B. Hypoglycemia and strict glycemic control in critically ill patients. Curr. Opin. Crit. Care 2008, 14:397-402.